MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Atara Biotherapeutics Total Inventories 2011-2026 | ATRA
Annual Total Inventories Atara Biotherapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.7 M | 9.71 M | 1.59 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.7 M | 1.59 M | 7.32 M |
Quarterly Total Inventories Atara Biotherapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 10.7 M | 14 M | 18.7 M | 16.1 M | 9.71 M | 6.59 M | 7.86 M | 5.34 M | 1.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.7 M | 1.59 M | 10.1 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K |  USA |
 |
ADMA Biologics
ADMA
|
206 M | $ 15.87 | -4.08 % | $ 3.78 B | USA |
 |
AbCellera Biologics
ABCL
|
6.34 M | $ 3.54 | -2.62 % | $ 1.06 B |  Canada |
 |
Aptorum Group Limited
APM
|
39.1 K | $ 0.82 | -0.73 % | $ 4.47 M |  China |
 |
Apellis Pharmaceuticals
APLS
|
143 M | $ 20.36 | 2.49 % | $ 2.57 B | USA |
 |
ANI Pharmaceuticals
ANIP
|
137 M | $ 75.13 | -1.83 % | $ 1.45 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
4.14 M | $ 1.51 | -7.36 % | $ 385 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
1.66 M | - | - | $ 521 M | USA |
 |
Axsome Therapeutics
AXSM
|
27.9 M | $ 162.19 | -1.15 % | $ 8.07 B | USA |
 |
BridgeBio Pharma
BBIO
|
26.8 M | $ 64.72 | -2.73 % | $ 12.4 B | USA |
 |
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | USA |
 |
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Berkeley Lights
BLI
|
18.9 M | - | -7.31 % | $ 87 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
1.3 B | $ 60.15 | -0.46 % | $ 11.5 B | USA |
 |
Agenus
AGEN
|
55.5 K | $ 3.02 | -5.63 % | $ 1.08 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
32.9 M | $ 27.77 | -1.49 % | $ 1.61 B | USA |